BAC
Bank of America Corporation
BAC has lower modeled downside risk, despite its lower overall score.
BX
Blackstone Inc.
BX has a slight edge over BAC overall, supported by stronger valuation and stronger modeled upside.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
BX Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BX's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BX.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over BX in the historical PE scenario, which offers more potential upside but is not a forecast.
BX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 17x | $77.47 | -35% |
| Forward | 18x | $119 | — |
| Current | 26x | $119 | — |
| Fair | 34x | $151 | +27% |
| Expensive | 58x | $259 | +118% |
Historical ranges are pointers, not guarantees.
BX's PE is in its fair range at 26x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over BX on the outlook, with more favorable profitability expectations.
BX Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for BX, with profitability holding steady. However, they disagree widely on these estimates.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
BX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.61 | +47% |
| Q3 2026 | $4.49 | +29% |
| Q2 2026 | $4.46 | +20% |
| Q1 2026 | $3.90 | +18% |
| Q4 2025 | $3.87 | +6.9% |
| Q3 2025 | $3.49 | +20% |
| Q2 2025 | $3.71 | +41% |
| Q1 2025 | $3.31 | +17% |
| Q4 2024 | $3.62 | +97% |
BX has the edge over BAC on earnings, with stronger typical year-over-year growth.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
BX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.1B | -0.8% |
| Q2 2026 | $5B | +36% |
| Q1 2026 | $3.6B | +10% |
| Q4 2025 | $4.4B | +41% |
| Q3 2025 | $3.1B | -16% |
| Q2 2025 | $3.7B | +33% |
| Q1 2025 | $3.3B | -11% |
| Q4 2024 | $3.1B | +140% |
BX's revenue is growing: $3.1B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 47% | +3.6 points |
| Q2 2026 | 53% | +5 points |
| Q1 2026 | 37% | -4.9 points |
| Q4 2025 | 51% | -0.1 points |
| Q3 2025 | 43% | -4.9 points |
| Q2 2025 | 48% | +6.3 points |
| Q1 2025 | 42% | -9 points |
| Q4 2024 | 51% | +25 points |
BX has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
BX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.9B | +22% |
| Q2 2026 | $1.9B | +125% |
| Q1 2026 | $957.6M | -11% |
| Q4 2025 | $1B | +599% |
| Q3 2025 | $1.6B | +31% |
| Q1 2025 | $1.1B | +17% |
| Q4 2024 | $149.5M | -83% |
| Q3 2024 | $1.2B | +18% |
BX has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over BX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
BX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +82.9K shares |
| 1 year | +2.2% | +17.3M shares |
| 3 years | +5.5% | +41.9M shares |
| 5 years | +11% | +77.5M shares |
| Available history | +18% | +124M shares |
BX has 800M diluted shares, up 2.2% from a year ago.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
BX Net Leverage
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
BX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.4 | Neutral |
| Stochastic | 29.9 | Neutral |
BX's weekly RSI is 45 (neutral) and its Stochastic is 30 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over BX on valuation relative to its sector.
BX PE vs Financial Services Sector
| Metric | BX | Sector median | Relative |
|---|---|---|---|
| PE | 26x | 13x | 103% above |
| PE % | 35 | 63 | 28 pts below |
BX is trading at 26x earnings, a 103% premium to the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
BX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $115.7 | 2.5% above |
| 20 week MA | $125.6 | 5.6% below |
| 50 week MA | $127.7 | 7.2% below |
| 100 week MA | $142.1 | 17% below |
| 200 week MA | $130.3 | 9% below |
BX has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 9% below its 200-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over BX on returns for 2026, with the stronger performance.
BX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $56.1 | $65.0 | +16% |
| 2021 | $65.0 | $135.0 | +108% |
| 2022 | $135.0 | $74.9 | -45% |
| 2023 | $74.9 | $130.9 | +75% |
| 2024 | $130.9 | $174.0 | +33% |
| 2025 | $174.0 | $155.4 | -11% |
| 2026 YTD | $155.4 | $118.5 | -24% |
BX's yearly returns have swung widely, from +108% in 2021 to −45% in 2022. It's down 24% so far in 2026.